Metabolic Syndrome

Subclinical Diabetic Cardiomyopathy: Detectable but Not Yet Actionable PFKFB2 Gates a Relationship Between Cardiac Glycolytic Regulation and Electrophysiological Function Distribution and Clinical Utility of the Kidney Disease Improving Global Outcomes Chronic Kidney Disease Risk Classification in Patients Undergoing Atrial Fibrillation Ablation Methylmalonate, a Metabolic Scar in the Diabetic Heart Associations of Cardiovascular–Kidney–Metabolic Syndrome With All‐Cause and Cardiovascular Death and the Progression of Cardiovascular–Kidney–Metabolic Syndrome Among Hong Kong Chinese People Over 2 Decades Elevated Endogenous Insulin and Insulin Resistance Are Associated With Progressive Diastolic Dysfunction and Worse Cardiovascular Outcomes Methodologic Standards for Follow-Up Extension in Cardiovascular Trials Rheumatologic Disease as a Substrate for HFpEF: Pathophysiological Mechanisms and Clinical Implications Therapeutic Translation of Epicardial Adipose Tissue Targeting in Heart Failure With Preserved Ejection Fraction: How Far Are We? Comprehensive Clinical Approach to Cardiovascular Kidney Metabolic Syndrome